Select Page
The Empire Strikes Back

The Empire Strikes Back

Earlier this year, I chronicled “Core Wars”, the ruthless ETF fee competition being waged over the core building blocks of a portfolio.  Investors continue plowing money into the lowest cost ETFs, resulting in fund companies battling for those dollars by engaging in a...
China Biotech: Innovation, Opportunity, and a New ETF

China Biotech: Innovation, Opportunity, and a New ETF

ETF innovation is truly staggering.  After hosting ETF Prime for 7+ years and visiting weekly with the brightest minds the industry has to offer, I can only compare the sheer level of talent and entrepreneurial spirit to Silicon Valley.  With so many unique and...
ETFs in Pictures II

ETFs in Pictures II

Earlier this year, I put nearly 20 of my favorite ETF-related charts in a single spot.  Images are often more powerful than words.  Based on the response I received, I decided to compile some new favorites, all of which I’ve come across over the past several months. ...
Fidelity Takes the Leap to Zero

Fidelity Takes the Leap to Zero

The first free index funds are finally here!  Tomorrow, Fidelity will unveil two broad-based, self-indexed mutual funds with a 0.00% fee.  In 2016, I made the prediction that several prominent ETFs will lower expense ratios to zero in 2017.  I was off by a year and...
Vanguard Goes Nuclear

Vanguard Goes Nuclear

“This is an unexpected move by Vanguard, and absolutely the next salvo in the ETF fee war.” – Dave Nadig, Managing Director of ETF.com   A ruthless ETF fee war escalated this week with Vanguard announcing 1,800+ ETFs (pretty much every ETF except...